Trade plays key roles in fostering innovation, both as a conduit for the diffusion of global technology and knowhow that facilitates innovation in developing nations and by giving innovative companies access to large global markets through which they can recoup their upfront investments in R&D and generate revenues to finance future generations of innovation. GTIPA-member reports here examine trade-innovation linkages.
Prosperity Index has plunged downwards.
On 23 June, the European Commission published the Innovation Scoreboard for 2020, the ranking of EU countries’ research and innovation performance. Results are broadly in line with those of previous years, with the Union as a whole strengthening its innovation capacity compared to the beginning of the decade, but continuing to lose positions to the major global competitors.
The Eastern European countries (especially the Baltic countries) have accelerated their growth and begun to reduce the internal European R&I divide. In contrast, Italy – although showing a positive trend during the decade – has confirmed its structural weaknesses in research and innovation, a factor that has been widely known for years. This is all further material for reflection, both at national and European levels, in view of the definition of the Recovery Plan proposed by the Commission at the end of May.
COVID-19 has prompted calls for reshoring of medical goods, including strict “Buy American” prescriptions. While reshoring is important, “Buy American” fails to recognize the value of the global supply chain and avoids addressing the real problem, China.
In the last 20 years, FDI in the world has grown faster than both exports and production, and has thus contributed strongly to the globalization. This report analyzes the impact of FDI on Swedish business.
This report examines the impact of acquiring foreign-owned companies in Sweden, and the improvements to productivity, human capital, and internationalization. Foreign-owned companies (and multi-national enterprises, or MNEs, in general) are more productive than non-MNEs in the same industry.
The extent to which follow-on pharmaceutical innovations should be protectable by patents is hotly debated amongst the public health and IP community in Geneva. But are fears that follow-on patents simply extend indefinitely, or “evergreening,” medicine patents justified?
Britain’s recent decision not to ban Huawei from its IT systems came as a sur
Separating the cost of biopharmaceutical research and development from the final market price of medicines would misalign incentives, raise bureaucratic costs, and limit innovation.
In recent years, Poland has benefitted from economic openness to see its digital sectors, like the gaming industry, and digitally enabled sectors, such as e‑commerce, develop and thrive. To sustain this development, it is crucial that the digital and digitally-enabled flows of goods, services, and data be strengthened even more.
In this report, the Swedish Agency for Growth Policy Analysis (Growth Analysi